Results 161 to 170 of about 19,362,621 (286)

Recommendations for definition and determination of carry‐over effects

Journal of Analytical Methods in Chemistry, 1988
openaire   +2 more sources

Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression

Molecular Oncology, EarlyView.
In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.
Eileen Wedge, Morten Tulstrup, Gabriele Todisco, Pedro Moura, Christophe Côme, Jakob Werner Hansen, Jakob Schmidt Jespersen, Balthasar Schlotmann, Maria Creignou, Mette Dahl, Claudia Schöllkopf, Klas Raaschou‐Jensen, Krister Wennerberg, Bo Porse, Joachim Weischenfeldt, Eva Hellström‐Lindberg, Lasse Sommer Kristensen, Kirsten Grønbæk   +17 more
wiley   +1 more source

carry-over

, 1968
carry vWith a carry-over of fish in Newfoundland it was possible for the John and Jane to arrive at St. John's on May 22 with 300 hogsheads of salt from Lisbon, to leave on June 10 with 1,000 quintails of fish for Lisbon ....PRINTED ITEM W.

core  

Carry-over effects between spring and autumn phenology differ among the world's biomes. [PDF]

Natl Sci Rev
Wu Z, Fu YH, Crowther TW, Renner SS, Vitasse Y, Mo L, Zou Y, Mirzagholi L, Li M, Rebindaine D, Gong Y, Guo Z, Wang N, Zohner CM.   +13 more
europepmc   +1 more source

No "carry-over" effects of tracking devices on return rate and parameters determining reproductive success in once and repeatedly tagged common swifts (Apus apus), a long-distance migratory bird. [PDF]

Mov Ecol, 2022
Wellbrock AHJ, Witte K.
europepmc   +1 more source

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

Molecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla, Christopher Dirks, Caroline Eiden, Sonja K. Fesenmayer, Femke M. Hormann, Yolande Klootsema, Ingrid Lilienthal, Si Min Zhang, Nikolas Herold, Sean G. Rudd   +9 more
wiley   +1 more source

Clarifying Order and Carry-Over Effects in Sequential MRgFUS Thalamotomy and Pallidothalamic Tract Ablation. [PDF]

Eur J Neurol
Aubignat M.
europepmc   +1 more source

Carry-over effects of dry period heat stress on the mammary gland proteome and phosphoproteome in the subsequent lactation of dairy cows. [PDF]

Sci Rep, 2022
Skibiel AL, Koh J, Zhu N, Zhu F, Yoo MJ, Laporta J.   +5 more
europepmc   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source

Other title: Concealed Carry Licensing in Kansas

, 2015
Includes bibliographical references.A set of 5 documents provided by the Concealed Carry Licensing Unit, Office of the Attorney General, with resources and information on Concealed Carry Licensing in Kansas.Kansas Concealed Carry Licensing (September 10,
Kansas Office of the Attorney General. Concealed Carry Licensing Unit.
core